BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 23928144)

  • 1. Utility of proton MR spectroscopy for differentiating typical and atypical primary central nervous system lymphomas from tumefactive demyelinating lesions.
    Lu SS; Kim SJ; Kim HS; Choi CG; Lim YM; Kim EJ; Kim DY; Cho SH
    AJNR Am J Neuroradiol; 2014 Feb; 35(2):270-7. PubMed ID: 23928144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton MR spectroscopy of tumefactive demyelinating lesions.
    Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
    Saini J; Chatterjee S; Thomas B; Kesavadas C
    Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas.
    Ikeguchi R; Shimizu Y; Abe K; Shimizu S; Maruyama T; Nitta M; Abe K; Kawamata T; Kitagawa K
    Mult Scler Relat Disord; 2018 Nov; 26():77-84. PubMed ID: 30237108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.
    Simone IL; Federico F; Tortorella C; Andreula CF; Zimatore GB; Giannini P; Angarano G; Lucivero V; Picciola P; Carrara D; Bellacosa A; Livrea P
    J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):516-23. PubMed ID: 9576546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton MR spectroscopy improves discrimination between tumor and pseudotumoral lesion in solid brain masses.
    Majós C; Aguilera C; Alonso J; Julià-Sapé M; Castañer S; Sánchez JJ; Samitier A; León A; Rovira A; Arús C
    AJNR Am J Neuroradiol; 2009 Mar; 30(3):544-51. PubMed ID: 19095788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging.
    Lai PH; Weng HH; Chen CY; Hsu SS; Ding S; Ko CW; Fu JH; Liang HL; Chen KH
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):1511-8. PubMed ID: 18499784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.
    Cianfoni A; Niku S; Imbesi SG
    AJNR Am J Neuroradiol; 2007 Feb; 28(2):272-7. PubMed ID: 17296993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
    Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
    AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
    Bulakbasi N; Kocaoglu M; Ors F; Tayfun C; Uçöz T
    AJNR Am J Neuroradiol; 2003 Feb; 24(2):225-33. PubMed ID: 12591638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
    J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
    Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
    Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
    Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
    J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating surgical from non-surgical lesions using perfusion MR imaging and proton MR spectroscopic imaging.
    Law M; Hamburger M; Johnson G; Inglese M; Londono A; Golfinos J; Zagzag D; Knopp EA
    Technol Cancer Res Treat; 2004 Dec; 3(6):557-65. PubMed ID: 15560713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.